Why do postmenopausal women discontinue hormone replacement therapy?

被引:51
作者
Vihtamäki, T [1 ]
Savilahti, R [1 ]
Tuimala, R [1 ]
机构
[1] Tampere Univ Hosp, Dept Obstet & Gynaecol, Tampere 33521, Finland
关键词
hormone replacement therapy; postmenopausal women; questionnaire; compliance;
D O I
10.1016/S0378-5122(99)00047-X
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To study the prevalence and acceptance of hormone replacement therapy (HRT) in the Finnish population and to ascertain the factors leading to premature discontinuation of HRT. Methods: A questionnaire survey was conducted among all women aged 50-60 selected from the age-sex register, 1065 women were identified and 884 (response rate 84%) agreed to participate. Results: 111 women were premenopausal and 773 postmenopausal; 302 (39%) were current HRT users, 126 (16%) previous users and 345 (45%) non-users. Of the previous users 27% had used oestrogen for less than 6 months and 46% had ceased treatment within 1 year. The main reason for discontinuation was side-effects; 41% of the women had suffered from them. Fear of cancer (16%), recommendation of a physician (12%), inefficiency (4%), and advice of a friend (3%) were other causes of discontinuation. Of the current users, 20% had continuous side-effects from the treatment and 15% had been advised to discontinue the treatment. Eleven percent of current users and 11% of previous users reported not having received any information about HRT. Conclusions: in this survey, more than half of postmenopausal women had used HRT at menopause. Every third of the women had discontinued the treatment, mainly because of side-effects but also because of fear of cancer and advice of physicians. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 24 条
[1]   STUDY OF GENERAL-PRACTICE CONSULTATIONS AND MENOPAUSAL PROBLEMS [J].
BARLOW, DH ;
BROCKIE, JA ;
REES, CMP .
BRITISH MEDICAL JOURNAL, 1991, 302 (6771) :274-276
[2]   17-BETA-ESTRADIOL AND CONTINUOUS NORETHISTERONE - A UNIQUE TREATMENT FOR ESTABLISHED OSTEOPOROSIS IN ELDERLY WOMEN [J].
CHRISTIANSEN, C ;
RIIS, BJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (04) :836-841
[3]  
CHRISTIANSEN C, 1981, LANCET, V1, P459
[4]   Endogenous hormones and the risk of hip and vertebral fractures among older women [J].
Cummings, SR ;
Browner, WS ;
Bauer, D ;
Stone, K ;
Ensrud, K ;
Jamal, S ;
Ettinger, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :733-738
[5]   LONG-TERM ESTROGEN REPLACEMENT THERAPY PREVENTS BONE LOSS AND FRACTURES [J].
ETTINGER, B ;
GENANT, HK ;
CANN, CE .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) :319-324
[6]   ESTROGEN REPLACEMENT THERAPY - A SURVEY OF WOMENS KNOWLEDGE AND ATTITUDES [J].
FERGUSON, KJ ;
HOEGH, C ;
JOHNSON, S .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (01) :133-136
[7]   HORMONE-THERAPY TO PREVENT DISEASE AND PROLONG LIFE IN POSTMENOPAUSAL WOMEN [J].
GRADY, D ;
RUBIN, SM ;
PETITTI, DB ;
FOX, CS ;
BLACK, D ;
ETTINGER, B ;
ERNSTER, VL ;
CUMMINGS, SR .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :1016-1037
[8]   UTILIZATION OF HORMONE REPLACEMENT THERAPY BY WOMEN DOCTORS [J].
ISAACS, AJ ;
BRITTON, AR ;
MCPHERSON, K .
BRITISH MEDICAL JOURNAL, 1995, 311 (7017) :1399-1401
[9]   A comparative study of prescribing of hormone replacement therapy in USA and Europe [J].
Jolleys, JV ;
Olesen, F .
MATURITAS, 1996, 23 (01) :47-53
[10]   ESTROGEN REPLACEMENT THERAPY - INDICATIONS AND COMPLICATIONS [J].
JUDD, HL ;
MELDRUM, DR ;
DEFTOS, LJ ;
HENDERSON, BE .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (02) :195-205